Key Takeaways
- • Private equity investment in U.S. health care surged from $41.5 billion in 2010 to $119.9 billion in 2019, with continued growth expected, driven by financial pressures on independent physician practices and shift toward institutional capital deployment.
- • The American College of Physicians (ACP) published a formal position paper in *Annals of Internal Medicine* calling for increased regulatory oversight of PE investments in health care, citing documented evidence linking PE ownership to higher patient costs, reduced clinical autonomy, and adverse effects on care delivery in certain settings.
- • PE firms have expanded acquisition targets beyond hospitals and nursing facilities to primary care and multispecialty physician practices, capitalizing on physician burnout, inadequate reimbursement rates, and practice funding constraints as consolidation drivers.
- • ACP recommendations focus on establishing a regulatory framework to protect three stakeholder groups: patients (care quality and affordability), physicians (clinical autonomy and workforce conditions), and the broader health care system (innovation and equity outcomes).
- • The policy gap is significant: PE-backed health care consolidation has been associated with higher out-of-pocket costs for patients and staffing/workforce composition changes in acquired practices and hospitals, yet regulatory mechanisms remain underdeveloped relative to PE capital deployment scale.
Summary
The American College of Physicians released a formal position paper on May 25, 2026, addressing the accelerating influence of private equity in U.S. health care and calling for enhanced regulatory oversight to protect patients and the physician workforce. Published in *Annals of Internal Medicine*, the paper titled "Regulatory Framework for Private Equity and Corporatization in Health Care: A Position Paper from the American College of Physicians" examines PE's impact across multiple dimensions—clinical autonomy, health care costs, quality, access, equity, and innovation.
Private equity capital deployment in health care has grown substantially, rising from $41.5 billion in 2010 to $119.9 billion in 2019, with growth trajectories expected to continue. This expansion reflects a strategic shift in PE targeting. Rather than concentrating exclusively on hospital and nursing facility acquisitions, PE firms have increasingly pursued primary care and multispecialty physician practices. This pivot is driven by structural vulnerabilities in independent practice economics: physicians face mounting practice operating costs, inadequate insurance reimbursement, and widespread burnout. As independent physicians retreat from private ownership, institutional capital—often from PE sponsors without health care operational expertise—has filled the capital gap.
Research cited by ACP documents concerning outcomes from PE acquisition. Evidence associates private equity ownership with elevated patient costs, higher out-of-pocket expenses, and in certain settings, deterioration in care delivery quality and patient outcomes. Additionally, PE acquisitions systematically alter staffing and workforce composition in acquired hospitals and physician practices, raising questions about labor practices and physician autonomy within PE-controlled entities.
ACP's position paper outlines specific policy recommendations designed to establish a regulatory framework balancing capital access for physician practices against patient protection and workforce stability. The organization emphasizes that while PE capital addresses real physician financial pressures, current regulatory gaps fail to prevent consolidation-driven cost inflation, care quality degradation, or clinical autonomy erosion. The recommendations target three constituencies: ensuring patient-centered care delivery standards, protecting physician clinical independence, and preserving innovation and equity outcomes in the broader health care system.
This intervention from a major physician organization signals institutional concern that PE's rapid expansion into primary care—the largest segment of U.S. health care—outpaces regulatory readiness and that voluntary corporate governance has proven insufficient to mitigate documented harms.
Private equity capital deployment in health care has grown substantially, rising from $41.5 billion in 2010 to $119.9 billion in 2019, with growth trajectories expected to continue. This expansion reflects a strategic shift in PE targeting. Rather than concentrating exclusively on hospital and nursing facility acquisitions, PE firms have increasingly pursued primary care and multispecialty physician practices. This pivot is driven by structural vulnerabilities in independent practice economics: physicians face mounting practice operating costs, inadequate insurance reimbursement, and widespread burnout. As independent physicians retreat from private ownership, institutional capital—often from PE sponsors without health care operational expertise—has filled the capital gap.
Research cited by ACP documents concerning outcomes from PE acquisition. Evidence associates private equity ownership with elevated patient costs, higher out-of-pocket expenses, and in certain settings, deterioration in care delivery quality and patient outcomes. Additionally, PE acquisitions systematically alter staffing and workforce composition in acquired hospitals and physician practices, raising questions about labor practices and physician autonomy within PE-controlled entities.
ACP's position paper outlines specific policy recommendations designed to establish a regulatory framework balancing capital access for physician practices against patient protection and workforce stability. The organization emphasizes that while PE capital addresses real physician financial pressures, current regulatory gaps fail to prevent consolidation-driven cost inflation, care quality degradation, or clinical autonomy erosion. The recommendations target three constituencies: ensuring patient-centered care delivery standards, protecting physician clinical independence, and preserving innovation and equity outcomes in the broader health care system.
This intervention from a major physician organization signals institutional concern that PE's rapid expansion into primary care—the largest segment of U.S. health care—outpaces regulatory readiness and that voluntary corporate governance has proven insufficient to mitigate documented harms.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.